China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4	4	5	23	19	10
Market Cap Growth	-25.86%	-19.49%	-78.32%	17.59%	88.26%	-8.00%
Enterprise Value	7	7	12	30	26	16
PE Ratio	-	-1.29	-1.25	-6.72	-6.78	-0.50
PS Ratio	0.62	0.57	0.61	2.37	1.79	0.95
PB Ratio	0.48	0.54	1.15	3.80	2.43	1.12
P/FCF Ratio	34.60	-5.61	-6.10	-33.21	-21.36	21.85
P/OCF Ratio	21.87	-5.70	-12.09	-91.44	-459.72	16.96
EV/Sales Ratio	1.14	1.02	1.44	3.15	2.38	1.44
EV/EBITDA Ratio	-12.69	845.46	-13.93	131.91	241.87	-0.90
EV/EBIT Ratio	-1.77	-2.60	-3.30	-10.63	-10.05	-0.77
EV/FCF Ratio	63.30	-10.03	-14.38	-44.17	-28.41	33.26
Debt / Equity Ratio	0.50	0.62	2.04	2.08	0.93	0.72
Debt / EBITDA Ratio	-9.16	549.38	-10.45	54.21	69.52	-0.38
Debt / FCF Ratio	35.94	-6.52	-10.79	-18.15	-8.17	14.02
Quick Ratio	0.22	0.32	0.23	0.54	0.14	0.19
Current Ratio	0.90	0.88	0.47	0.87	0.47	0.56
Asset Turnover	0.40	0.43	0.44	0.48	0.50	0.29
Interest Coverage	-11.01	-8.23	-8.14	-5.27	-8.75	-63.35
Return on Equity (ROE)	-54.30%	-54.50%	-96.40%	-51.20%	-35.10%	-86.10%
Return on Assets (ROA)	-22.30%	-19.00%	-21.80%	-16.90%	-13.10%	-55.10%
Return on Capital (ROIC)	-26.25%	-22.76%	-27.20%	-15.46%	-16.71%	-128.68%
Earnings Yield	-88.76%	-77.22%	-80.22%	-14.88%	-14.76%	-200.61%
FCF Yield	2.89%	-17.84%	-16.39%	-3.01%	-4.68%	4.58%
Buyback Yield / Dilution	-712.82%	-221.82%	-13.96%	-5.74%	-0.10%	-
Total Shareholder Return	-712.82%	-221.82%	-13.96%	-5.74%	-0.10%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).